
Betmiga — mirabegron 50 mg, prolonged-release tablets, 30 tablets
Brand: Astellas Pharma
+ delivery from €40
Betmiga 50 mg: mirabegron, prolonged-release tablets, 30 tablets. An Astellas Pharma brand.
Key information
Full description
Betmiga 50 mg contains mirabegron and belongs to the medicines for treating the symptoms of overactive bladder. It may be used for frequent and urgent urination and episodes of urge incontinence. The tablets are prolonged-release. The treatment regimen, duration of use and compatibility with other medicines are determined by the doctor.
Frequently asked questions
What is Betmiga 50 mg used for?
Betmiga is used to treat the symptoms of overactive bladder in adults.
How does Betmiga differ from Vesicare?
Betmiga contains mirabegron and acts via β3-adrenergic receptors, while Vesicare contains solifenacin and is an antimuscarinic medicine.
What does prolonged release mean for Betmiga?
The active ingredient is released gradually, so the tablet is used in the form provided by the manufacturer.
Why is the Betmiga tablet swallowed whole?
Keeping the tablet intact helps preserve the intended prolonged-release profile.
Other medicines in Urology and kidneys
- Vardenafilo STADA 10 mg — film-coated tablets, 8 pcs€65
- Vesicare — solifenacin 10 mg, film-coated tablets, 30 tablets€83
- Vesomni — solifenacin/tamsulosin 6/0.4 mg, modified-release tablets, 30 tablets€61
- Viagra — sildenafil 25 mg, tablets, 4 tablets€99
- Ditropan — oxybutynin hydrochloride, 5 mg, tablets, 60 pcs.€25
- Intrarosa — prasterone 6.5 mg, pessaries, 28 pcs. + 6 applicators€65
- Caverject — alprostadil 10 mcg, powder and solvent for injection€29
- Caverject — alprostadil 20 mcg, powder and solvent for injection€39
How to order
Tap the button for your preferred messenger. A manager will check availability, confirm the price and ask for your full delivery address.
This information is for reference only. Consult a doctor and read the official package leaflet before use.